It is primarily linked to: CEA is mainly released from epithelial tumors, LC originates from the bronchial mucosal epithelium, and SCC is an antigen generated and secreted by LSCC [19], [20]. Here, CEACAM5 is linked to laryngotracheoesophageal cleft.